Research output per year
Research output per year
Search results
-
2021
Risk-stratified sequential treatment with ibrutinib and rituximab (IR) and IR-CHOP for de-novo post-transplant lymphoproliferative disorder: results of the tidal trial
Chaganti, S., Maycock, S., Mcilroy, G., Iqbal, W. A., Mason, J., Kanfer, E., Kassam, S., Cwynarski, K., Wrench, D., Arumainathan, A. K., Fox, C. P., Johnson, R., Mckay, P., Paneesha, S., Rowntree, C. J., Balotis, C., Collins, G. P., Davies, A., Wright, J., Wheatley, K., & 1 others, 23 Nov 2021, In: Blood. 138, Supplement 1, p. 2492-2492 1 p., 2492.Research output: Contribution to journal › Abstract